169 related articles for article (PubMed ID: 37310006)
1. Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months.
Santopaolo M; Gregorova M; Hamilton F; Arnold D; Long A; Lacey A; Oliver E; Halliday A; Baum H; Hamilton K; Milligan R; Pearce O; Knezevic L; Morales Aza B; Milne A; Milodowski E; Jones E; Lazarus R; Goenka A; Finn A; Maskell N; Davidson AD; Gillespie K; Wooldridge L; Rivino L
Elife; 2023 Jun; 12():. PubMed ID: 37310006
[TBL] [Abstract][Full Text] [Related]
2. Persistent High Percentage of HLA-DR
Du J; Wei L; Li G; Hua M; Sun Y; Wang D; Han K; Yan Y; Song C; Song R; Zhang H; Han J; Liu J; Kong Y
Front Immunol; 2021; 12():735125. PubMed ID: 34567001
[TBL] [Abstract][Full Text] [Related]
3. CD4
Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
[No Abstract] [Full Text] [Related]
4. Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients.
Rovito R; Bono V; Augello M; Tincati C; Mainoldi F; Beaudoin-Bussières G; Tauzin A; Bianchi S; Hadla M; Yellenki V; d'Arminio Monforte A; Casola S; Borghi E; Finzi A; Marchetti G
Sci Rep; 2022 Nov; 12(1):19658. PubMed ID: 36385627
[TBL] [Abstract][Full Text] [Related]
5. Persistent CD8
LaVergne SM; Dutt TS; McFann K; Baxter BA; Webb TL; Berry K; Tipton M; Stromberg S; Sullivan BM; Dunn J; Henao-Tamayo M; Ryan EP
Front Immunol; 2023; 14():1303971. PubMed ID: 38327763
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
Bergamaschi L; Mescia F; Turner L; Hanson AL; Kotagiri P; Dunmore BJ; Ruffieux H; De Sa A; Huhn O; Morgan MD; Gerber PP; Wills MR; Baker S; Calero-Nieto FJ; Doffinger R; Dougan G; Elmer A; Goodfellow IG; Gupta RK; Hosmillo M; Hunter K; Kingston N; Lehner PJ; Matheson NJ; Nicholson JK; Petrunkina AM; Richardson S; Saunders C; Thaventhiran JED; Toonen EJM; Weekes MP; ; Göttgens B; Toshner M; Hess C; Bradley JR; Lyons PA; Smith KGC
Immunity; 2021 Jun; 54(6):1257-1275.e8. PubMed ID: 34051148
[TBL] [Abstract][Full Text] [Related]
7. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.
Wiech M; Chroscicki P; Swatler J; Stepnik D; De Biasi S; Hampel M; Brewinska-Olchowik M; Maliszewska A; Sklinda K; Durlik M; Wierzba W; Cossarizza A; Piwocka K
Front Immunol; 2022; 13():886431. PubMed ID: 35757700
[TBL] [Abstract][Full Text] [Related]
8. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
9. Mild Cytokine Elevation, Moderate CD4
Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
[TBL] [Abstract][Full Text] [Related]
10. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
Front Immunol; 2022; 13():769839. PubMed ID: 35422799
[TBL] [Abstract][Full Text] [Related]
11. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.
Patterson BK; Guevara-Coto J; Yogendra R; Francisco EB; Long E; Pise A; Rodrigues H; Parikh P; Mora J; Mora-Rodríguez RA
Front Immunol; 2021; 12():700782. PubMed ID: 34262570
[TBL] [Abstract][Full Text] [Related]
12. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
Gozzi-Silva SC; Oliveira LM; Alberca RW; Pereira NZ; Yoshikawa FS; Pietrobon AJ; Yendo TM; de Souza Andrade MM; Ramos YAL; Brito CA; Oliveira EA; Beserra DR; Orfali RL; Aoki V; Duarte AJDS; Sato MN
Cells; 2022 Oct; 11(21):. PubMed ID: 36359755
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Impairs Immune Response to
Moser D; Biere K; Han B; Hoerl M; Schelling G; Choukér A; Woehrle T
Front Immunol; 2021; 12():640644. PubMed ID: 33717195
[TBL] [Abstract][Full Text] [Related]
14. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients.
González-Cuadrado C; Caro-Espada PJ; Chivite-Lacaba M; Utrero-Rico A; Lozano-Yuste C; Gutierrez-Solis E; Morales E; Sandino-Pérez J; Gil-Etayo FJ; Allende-Martínez L; Laguna-Goya R; Paz-Artal E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675231
[TBL] [Abstract][Full Text] [Related]
15. Immune modulation as a consequence of SARS-CoV-2 infection.
Gelmez MY; Oktelik FB; Tahrali I; Yilmaz V; Kucuksezer UC; Akdeniz N; Cetin EA; Kose M; Cinar C; Oguz FS; Besisik S; Koksalan K; Ozdemir O; Senkal N; Gul A; Tuzun E; Deniz G
Front Immunol; 2022; 13():954391. PubMed ID: 36110850
[TBL] [Abstract][Full Text] [Related]
16. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
[TBL] [Abstract][Full Text] [Related]
17. T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.
Taeschler P; Adamo S; Deng Y; Cervia C; Zurbuchen Y; Chevrier S; Raeber ME; Hasler S; Bächli E; Rudiger A; Stüssi-Helbling M; Huber LC; Bodenmiller B; Boyman O; Nilsson J
Allergy; 2022 Aug; 77(8):2468-2481. PubMed ID: 35567391
[TBL] [Abstract][Full Text] [Related]
18. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
[TBL] [Abstract][Full Text] [Related]
19. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
20. Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery.
Ruenjaiman V; Sodsai P; Kueanjinda P; Bunrasmee W; Klinchanhom S; Reantragoon R; Tunvirachaisakul C; Manothummetha K; Mejun N; Liengswangwong K; Torvorapanit P; Paitoonpong L; Putcharoen O; Palaga T; Hirankarn N;
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):993-1004. PubMed ID: 36220753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
